A phase I, open-label, 2-part study to establish absolute bioavailability and the absorption, metabolism and excretion of evogliptin in healthy male subjects by a light-label approach

詳細情報 詳細情報について

• CRID

  1361415748537251584

• NII論文ID

  210000181537

• DOI

  10.1016/j.dmpk.2016.10.307

• ISSN

  13474367

• Web Site

  https://api.elsevier.com/content/article/PII:S1347436716304219?httpAccept=text/plain

  https://api.elsevier.com/content/article/PII:S1347436716304219?httpAccept=text/xml

• データソース種別

  • Crossref
  • CiNii Articles